These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3086724)

  • 21. [Clinical pharmacology of anti-arrhythymia agents. II. Lignocaine, mexiletine, tocainide, phenytoin].
    Witkowska M
    Kardiol Pol; 1981; 24(11-12):803-13. PubMed ID: 6804681
    [No Abstract]   [Full Text] [Related]  

  • 22. [New anti-arrhythmia drugs].
    Vidal Garate J; Romero-Ayala LC; Cárdenas Loaeza M
    Arch Inst Cardiol Mex; 1983; 53(2):159-78. PubMed ID: 6411015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral tocainide versus disopyramide: a double-blind, randomized, crossover study of outpatients with stable ventricular premature beats.
    McLaran CJ; Hossack KF; Neilson GH; Siskind V
    J Cardiovasc Pharmacol; 1984; 6(4):657-62. PubMed ID: 6206321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Perspectives in anti-arrhythmia pharmacological therapy].
    Furlanello F; Vergara G; Inama G; Dal Forno P; Bettini R; Disertori M
    Cardiologia; 1984; 29(1-2):73-84. PubMed ID: 6442869
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparative studies of tocainide and propafenone in the treatment of ventricular arrhythmias].
    Gebhardt A; Schmuderer R; Hilpert P
    Arzneimittelforschung; 1984; 34(3):303-6. PubMed ID: 6428425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New insights into the drug treatment of ventricular arrhythmias.
    Nestico PF; Morganroth J
    Int J Dermatol; 1984 Oct; 23(8):558-64. PubMed ID: 6437997
    [No Abstract]   [Full Text] [Related]  

  • 27. Tocainide.
    Danilo P
    Am Heart J; 1979 Feb; 97(2):259-62. PubMed ID: 760455
    [No Abstract]   [Full Text] [Related]  

  • 28. Antiarrhythmic drug therapy (Part 2). Benefits and hazards.
    Podrid PJ
    Chest; 1985 Oct; 88(4):618-24. PubMed ID: 3930162
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of tocainide enantiomers on experimental arrhythmias produced by programmed electrical stimulation.
    Uprichard AC; Allen JD; Harron DW
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):235-41. PubMed ID: 2452320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Double-blind randomized comparison of intravenous tocainide versus lidocaine in the treatment of chronic ventricular arrhythmias.
    Mohiuddin SM; Hilleman DE; Mooss AN; Esterbrooks D; Sketch MH; Stengel LA; Butler ML
    Am Heart J; 1987 Aug; 114(2):296-302. PubMed ID: 3111238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in antiarrhythmic therapy. The role of newer antiarrhythmic drugs.
    Nademanee K; Singh BN
    JAMA; 1982 Jan; 247(2):217-22. PubMed ID: 6796709
    [No Abstract]   [Full Text] [Related]  

  • 32. Tocainide (Tonocard) for ventricular arrhythmias.
    Pepper GA
    Nurse Pract; 1985 Apr; 10(4):36, 38. PubMed ID: 3921883
    [No Abstract]   [Full Text] [Related]  

  • 33. Antimyotonic therapy with tocainide under ECG control in the myotonic dystrophy of Curschmann-Steinert.
    Mielke U; Haass A; Sen S; Schmidt W
    J Neurol; 1985; 232(5):271-4. PubMed ID: 3932602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New drugs in the management of ventricular arrhythmias.
    Sanna GP
    G Ital Cardiol; 1984 Oct; 14(10):788-97. PubMed ID: 6083894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical pharmacology of antiarrhythmic drugs: a review and overview, part II.
    Singh BN; Cho YW; Kuemmerle HP
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):185-99. PubMed ID: 6788721
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of hypertensive patients with ventricular arrhythmias: comparison and combination of beta-blocker and anti-arrhythmic therapy.
    Di Somma S; Savonitto S; Petitto M; Liguori V; Magnotta C; de Divitiis O
    J Int Med Res; 1989; 17(2):113-24. PubMed ID: 2498141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of long-term antiarrhythmic therapy: studies on the long-term efficacy and toxicity of tocainide.
    Engler R; Ryan W; LeWinter M; Bluestein H; Karliner JS
    Am J Cardiol; 1979 Mar; 43(3):612-8. PubMed ID: 420111
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative study of tocainide and lidocaine in patients admitted for suspected acute myocardial infarction.
    Rehnqvist N; Erhardt L; Ericsson CG; Olsson G; Svensson G; Sjögren A
    Acta Med Scand; 1983; 214(1):21-7. PubMed ID: 6414252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ventricular arrhythmias. An assessment of newer therapeutic agents.
    Skluth H; Grauer K; Gums J
    Postgrad Med; 1989 May; 85(6):137-8, 141-8, 153. PubMed ID: 2496401
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy and safety of oral tocainide in refractory ventricular arrhythmia: a preliminary report on an open label study.
    Mahapatra RK; Mahapatra D
    Angiology; 1986 Apr; 37(4):285-93. PubMed ID: 2424347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.